139 related articles for article (PubMed ID: 23447383)
1. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients.
Piechnik A; Dmoszynska A; Omiotek M; Mlak R; Kowal M; Stilgenbauer S; Bullinger L; Giannopoulos K
Int J Cancer; 2013 Sep; 133(6):1489-96. PubMed ID: 23447383
[TBL] [Abstract][Full Text] [Related]
2. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin 1: function and therapeutic potential in cancer.
Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Cancer Immunol Immunother; 2014 Feb; 63(2):81-99. PubMed ID: 24263240
[TBL] [Abstract][Full Text] [Related]
4. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
[TBL] [Abstract][Full Text] [Related]
5. Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma.
Karczmarczyk A; Bilska S; Korpysz M; Purkot J; GrzĄŚko N; Hus M; Giannopoulos K
Anticancer Res; 2020 Oct; 40(10):5437-5443. PubMed ID: 32988865
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer.
Staton CA; Koay I; Wu JM; Hoh L; Reed MW; Brown NJ
Histopathology; 2013 May; 62(6):908-15. PubMed ID: 23551578
[TBL] [Abstract][Full Text] [Related]
7. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
Miao HQ; Lee P; Lin H; Soker S; Klagsbrun M
FASEB J; 2000 Dec; 14(15):2532-9. PubMed ID: 11099472
[TBL] [Abstract][Full Text] [Related]
12. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
[TBL] [Abstract][Full Text] [Related]
13. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
14. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.
Giannopoulos K; Schmitt M; Własiuk P; Chen J; Bojarska-Junak A; Kowal M; Roliñski J; Dmoszyñska A
Leukemia; 2008 Jan; 22(1):222-4. PubMed ID: 17657216
[No Abstract] [Full Text] [Related]
15. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.
Bourbié-Vaudaine S; Blanchard N; Hivroz C; Roméo PH
J Immunol; 2006 Aug; 177(3):1460-9. PubMed ID: 16849452
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Giannopoulos K; Dmoszynska A; Kowal M; Wasik-Szczepanek E; Bojarska-Junak A; Rolinski J; Döhner H; Stilgenbauer S; Bullinger L
Leukemia; 2009 Oct; 23(10):1771-8. PubMed ID: 19440214
[TBL] [Abstract][Full Text] [Related]
20. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
